Advertisement
Advertisement

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

25.60
USD
Sponsored
-0.35
-1.35%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

25.51

-0.09
-0.35%

PLSE Earnings Reports

Positive Surprise Ratio

PLSE beat 11 of 24 last estimates.

46%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$544.00K
/
-$0.36
Implied change from Q1 26 (Revenue/ EPS)
+35.66%
/
+50.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+80.00%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On May 04, 2026, PLSE reported earnings of -0.24 USD per share (EPS) for Q1 26, beating the estimate of -0.32 USD, resulting in a 25.30% surprise. Revenue reached 401.00 thousand, compared to an expected 408.00 thousand, with a -1.72% difference. The market reacted with a -3.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 544.00 thousand USD, implying an increase of 50.00% EPS, and increase of 35.66% in Revenue from the last quarter.
FAQ
For Q1 2026, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.24, beating estimates by 25.3%, and revenue of $401.00K, -1.72% below expectations.
The stock price moved down -3.84%, changed from $20.83 before the earnings release to $20.03 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 3 analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.36 and revenue of $544.00K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement